Imaging modalities used in the diagnosis of multiple myeloma have evolved and most of them are also suitable for either early or mid-term monitoring of response to novel antimyeloma therapy. This pictorial essay focuses on modern imaging techniques for diagnosis and follow-up of patients with multiple myeloma in order to highlight their individual strengths and limitations. Also, the impact of recently established modern pharmaceutical therapy, like anti-angiogenic medication, on the tumor is addressed.
DurieBG, HarousseauJL, MiguelJS, International uniform response criteria for multiple myeloma. Leukemia2006;20:1467–73
3.
HorgerM, KanzL, DeneckeB, The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma. Cancer2007;109:1617–26
4.
DurieBG, SalmonSE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer1975;36:842–54
5.
WahlinA, HolmJ, OstermanG, Evaluation of serial bone X-ray examination in multiple myeloma. Acta Med Scand1982;212:385–7
6.
DinterDJ, NeffWK, KlausJ, Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy. Ann Hematol2009;88:457–64
7.
HorgerM, ClaussenCD, Bross-BachU, Whole-Body Low-Dose Multidetector Row-CT in the Diagnosis of Multiple Myeloma: An Alternative to Conventional Radiography. Eur J Radiol2004;54:289–97
8.
MahnkenAH, WildbergerJE, GehbauerG, Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. Am J Roentgenol2002;178:1429–36
9.
LecouvetF, Vande BergB, MalghemJ, Magnetic resonance imaging in multiple myeloma. Semin Musculoskelet Radiol2001;5:43–55
10.
LecouvetFE, MelghemJ, MichauxL, Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey. Br J Haematol1999;106:35–9
11.
LibshitzHI, MalthouseSR, CunninghamD, Magnetic resonance appearance of multiple myeloma. Radiology1992;182:833–7
12.
DelormeS, Baur-MelnykA. Imaging in multiple myeloma. Eur J Radiol2009;70:401–8
13.
BredellaMA, SteinbachL, CaputoG, Value of FDG PET in the assessment of patients with multiple myeloma. Am J Roentgenol2005;184:1199–204
GleesonTG, MoriartyJ, ShorttCP, Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI). Skeletal Radiol2009;38:225–36
16.
RichardsonPG, SonneveldP, SchusterMW, Assessment of proteasome inhibition for extending remissions (APEX) investigators. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med2005;352:2487–98
17.
SchmidtGP, SchoenbergSO, ReiserMF, Whole-body MR imaging of bone marrow. Eur J Radiol2005;55:33–40
18.
DurieGMB. The role of anatomic and functional staging in multiple myeloma: Description of Durie/Salmon plus staging system. Eur J Cancer2006;42:1539–43
19.
Nosàs-GarciaS, MoehlerT, WasserK, Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markers. J Magn Reson Imaging2005;22:154–62
FenchelM, KonaktchievaM, WeiselK, Response assessment in patients with multiple myeloma during antiangiogenic therapy using arterial spin labeling and diffusion-weighted imaging: a feasibility study. Acad Radiol2010;17:1326–33
22.
FenchelM, KonaktchievaM, WeiselK, Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results. Eur Radio. 2010;20:899–906
23.
LinC, IttiE, LucianiA, Whole-body diffusion-weighted imaging in lymphoma. Cancer Imaging2010;10:172–8
24.
KweeTC, TakaharaT, OchiaiR, Complementary roles of whole-body diffusion-weighted MRI and 18F-FDG PET: the state of the art and potential applications. J Nucl Med2010;51:1549–58
25.
HanrahanCJ, ChristensenCR, CrimJR. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT. Radiographics2010;30:127–42
26.
ShorttCP, GleesonTG, BreenKA, Whole-Body MRI versus PET in assessment of multiple myeloma disease activity. Am J Roentgenol2009:192:980–6
27.
HurJ, YoonCS, RyuYH, Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography. J Comput Assist Tomogr2007:31:342–7
